MEN 10627

Drug Profile

MEN 10627

Latest Information Update: 20 Oct 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Menarini
  • Class Antiasthmatics; Muscle relaxants
  • Mechanism of Action Neurokinin 2 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Gastrointestinal disorders

Most Recent Events

  • 20 Oct 1998 Discontinued-Preclinical for Asthma in Italy (Unknown route)
  • 20 Oct 1998 Discontinued-Preclinical for Gastrointestinal disorders in Italy (Unknown route)
  • 01 Sep 1997 Preclinical development for Gastrointestinal disorders in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top